April 22, 2026

Side Effects: Salt, Steroids, and Second Brains

So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.

Conexiant

April 21, 2026

Type 2 Diabetes Linked to SSNHL Risk

Mendelian randomization analysis shows independent association, with no link for type 1 diabetes, obesity, or hyperlipidemia.

Conexiant

April 20, 2026

BMI-Adjusted Grip Strength and Sarcopenia in Prediabetes

Researchers report 8% prevalence of probable sarcopenia and a 96.4% specificity cutoff for BMI-adjusted grip strength.

Conexiant

April 17, 2026

Bundled Care Strategy May Reduce Moderate to Severe AKI

Multicenter trial finds KDIGO-recommended approach lowers moderate to severe acute kidney injury; measured 90-day outcomes were similar between groups

Conexiant

April 17, 2026

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Conexiant

April 17, 2026

Incretin Trials Often Exceed Muscle-Loss Benchmarks

Systematic review finds muscle-related losses frequently surpass expected thresholds during weight loss, though clinical impact remains unclear

Conexiant

April 17, 2026

Retinal Imaging Model Aids CAD Detection

Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort

Conexiant

April 17, 2026

Remote Monitoring Lowers Postpartum BP

Meta-analysis finds telemonitoring improves blood pressure after hypertensive pregnancy, while medications show no clear benefit

Conexiant

April 16, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Conexiant

April 15, 2026

ApoB Goal Cost-Effective in Primary Prevention

Strategy increased quality-adjusted life-years and showed favorable cost-effectiveness vs low-density lipoprotein cholesterol and non–high-density lipoprotein cholesterol goals

Conexiant